We must harness technology to deliver the musculoskeletal disease epidemiology that is urgently needed across sub-Saharan Africa

Affiliations

¹ Department of Infection and Immunity, University College London (UCL), London, WC1E 6BT, UK. douglas.fink@nhs.net.
² Department of Clinical Sciences, Nigerian Institute of Medical Research (NIMR), Lagos, Nigeria.
³ Department of Maternal Medicine, Guy's and St Thomas's NHS Foundation Trust, London, UK.
⁴ Rheumatology Department, Lagos State University College of Medicine, Lagos, Nigeria.
⁵ Rheumatology Department, School of Medicine and Dentistry, Korle Bu Teaching Hospital, Accra, Ghana.

Comment

Doug L Fink et al. Clin Rheumatol. 2018 May.

. 2018 May;37(5):1439-1440.

doi: 10.1007/s10067-018-4020-7. Epub 2018 Feb 8.

¹ Department of Infection and Immunity, University College London (UCL), London, WC1E 6BT, UK. douglas.fink@nhs.net.
² Department of Clinical Sciences, Nigerian Institute of Medical Research (NIMR), Lagos, Nigeria.
³ Department of Maternal Medicine, Guy's and St Thomas's NHS Foundation Trust, London, UK.
⁴ Rheumatology Department, Lagos State University College of Medicine, Lagos, Nigeria.
⁵ Rheumatology Department, School of Medicine and Dentistry, Korle Bu Teaching Hospital, Accra, Ghana.

No abstract available

Comment on

Prevalence of musculoskeletal diseases in a semi-urban Nigerian community: results of a cross-sectional survey using COPCORD methodology.
Courage UU, Stephen DP, Lucius IC, Ani C, Oche AO, Emmanuel AI, Olufemi AO. Courage UU, et al. Clin Rheumatol. 2017 Nov;36(11):2509-2516. doi: 10.1007/s10067-017-3648-z. Epub 2017 Apr 26. Clin Rheumatol. 2017. PMID: 28447235